Healing Together: Lifestyle Medicine Group Visits Help Patients Manage Chronic Disease. Healing Together: Lifestyle Medicine Group Visits Help Patients Manage Chronic Disease. Providers at Mass General are taking steps to make care more effective,
Browse Mass General News
In U.S. patients who underwent major cancer operations, the incidence of suicide was significantly higher than the general population.
Driving at Night in the Fog: Sonia Vallabh and Eric Minikel’s Unique Path to a Cure for Prion Disease
The process of getting a drug to patients is cumbersome and heroic. For Drs. Sonia Vallabh and Eric Minikel, who founded the Prion (pronounced “pree-on”) Alliance to develop therapeutics for human prion disease, their path has been, they say, like “driving at night in the fog.” Learn more.
The American Academy of Sleep Medicine recommends that adults get seven or more hours of sleep per night to avoid the health risks associated with chronic inadequate sleep.
Researcher Discover Why Only Some People Experience Long-Term Benefits from Peanut Allergy Treatments
The findings may help investigators improve allergy treatments so that all patients can benefit.
The drug delays tumor growth and increases glioblastoma cells’ sensitivity to anticancer therapies.
An Explainable Artificial Intelligence Approach to Predicting Oxygen Requirement in COVID-19 Patients from Chest X-Rays
The method can easily be repurposed for new problems using explainable artificial intelligence (xAI).
Modified CRISPR-Based Enzymes Improve the Prospect of Inserting Entire Genes into the Genome to Overcome Diverse Disease-Causing Mutations
Investigators have developed an improved method to more accurately insert large DNA sequences–such as an entire normal replacement gene—in cells.
Clinical Trial Results Indicate Low Rate of Adverse Events Associated With Implanted Brain Computer Interface
Results from the largest and longest-running clinical trial of an implanted brain computer interface suggests that the investigational BrainGate Neural Interface system safety is comparable to other chronically implanted devices used to manage neurologic disease.
Using information from a single low-dose chest computed tomography scan, ‘Sybil’ accurately predicted individuals’ lung cancer risk for one to six years in the future, pointing a way toward personalized screening.